Aperta Biosciences is Biotechnology in United States that focus on underlying causes business. Founded in 2017. They cover business area such as operator, chronic inflammatory ophthalmic disease, novel treatment, ocular surface disease, blepharitis, user, assistance, ocular rosacea, meibomian gland, dysfunction, dry eye disease.
2017
( 7 years old in 2024 )
Underlying Causes
-
1601 Trinity Street
Building B, Suite 3.306 (Health Discovery Building)
Austin, TX 78701
United States
Private
operatorchronic inflammatory ophthalmic diseasenovel treatmentocular surface diseaseblepharitisuserassistanceocular rosaceameibomian glanddysfunctiondry eye disease
* We use standard office opening hours in near Aperta Biosciences's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Aperta Biosciences is Biotechnology business from United States that founded in 2017 (7 years old in 2024), Aperta Biosciences business is focusing on Underlying Causes.
Aperta Biosciences headquarter office and corporate office address is located in 1601 Trinity Street Building B, Suite 3.306 (Health Discovery Building) Austin, TX 78701 United States.
Aperta Biosciences was founded in United States.
In 2024, Aperta Biosciences is currently focus on underlying causes sector.
Above is snippet of Google Trends for "underlying causes" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Aperta Biosciences, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
